Dr Umi Kalsom Yusof (umi.kalsom@might.org.my)
Dr Abdul Rahman Hamdan (rahman@might.org.my)
Muhaizzah Murad (muhaizzah@might.org.my)
Introduction
Artificial Intelligence (AI) is rapidly becoming a cornerstone of digital transformation in healthcare worldwide. In Malaysia, there is growing momentum toward embedding AI into national healthcare strategies, encompassing early diagnostics, hospital workflow automation and predictive care delivery. This drive is further strengthened by the United Kingdom (UK)–Malaysia AI Growth Partnership study, a flagship initiative underpinned by robust trade agreements and digital cooperation frameworks between the two nations. This article focuses on the medical and healthcare domain in highlighting how the collaboration links the UK’s mature AI ecosystem with the Malaysian landscape to catalyse impactful and responsible innovation.
The Malaysian Landscape: Progress in AI-Driven Healthcare
Malaysia has made significant strides in integrating AI across its healthcare ecosystem, marking a promising future for healthcare. A key initiative is the Ministry of Health’s National Lung Health Initiative 2025–2030, which has introduced AI-powered X-ray screening systems in seven primary care clinics. This initiative targets early detection of chronic lung conditions such as cancer and pneumonia. According to Health Minister Dr. Dzulkefly Ahmad, AI significantly improves the accuracy and efficiency of diagnostic screenings, reinforcing a strategic shift toward preventive and cost-effective healthcare.
In the private sector, KPJ Healthcare has adopted AI to streamline hospital operations and improve patient engagement. In collaboration with IBM Malaysia and GlobeOSS, KPJ has deployed an AI-powered chatbot built on IBM WatsonX across 30 specialist hospitals. The system manages appointment scheduling, answers frequently asked questions, and facilitates communication with specialists. This 24/7 virtual assistant reduces administrative workload while improving patient satisfaction through timely and accurate interactions.
Regulatory support keeps pace with technological innovation. In late 2024, Malaysia’s Medical Device Authority (MDA) updated its framework for Software as a Medical Device (SaMD), shifting toward a version-control-based approach for product registration. This more agile process accelerates the approval of AI-enabled clinical tools while maintaining traceability and safety oversight.
However, the growing adoption of AI also highlights the need for stronger ethical and legal frameworks. Malaysian experts emphasise that AI should augment, not replace, human decision-making. Currently, clinicians remain liable for outcomes involving AI-driven tools, highlighting an urgent need for clear policies on accountability, transparency and informed consent. These considerations are critical as Malaysia scales its AI adoption across the healthcare continuum.
Challenges in Malaysia’s AI Healthcare Ecosystem
Malaysia’s approach combines policy leadership, innovative infrastructure and public–private collaboration. However, several challenges remain that must be addressed to ensure equitable and sustainable AI deployment.
The UK–Malaysia Partnership: Synergy for Responsible Innovation
The United Kingdom offers capabilities that complement Malaysia’s healthcare ambitions. With established ethical AI frameworks, world-class universities and advanced medical R&D institutions, the UK plays a pivotal role in advancing responsible AI deployment in Malaysia.UK-supported research grants and Proof of Concept (PoC) funding have enabled Malaysian startups and universities to pilot AI tools in clinical environments. Platforms
such as Universiti Malaya’s Health Metropolis and startups like XITRON are actively involved in validating AI models using real-world patient data. These partnerships not only support knowledge transfer but also strengthen Malaysia’s capacity to scale AI training, governance and evaluation through shared dashboards and institutional networks.
On the regulatory front, Malaysia is actively benchmarking global best practices, as such drawing from the United Kingdom’s National AI Strategy. With advisory input from UK-based institutions, Malaysia is shaping its own ethical and regulatory framework that reflects local healthcare needs while aligning with internationally trusted models.
This partnership also plays a critical role in addressing Malaysia’s talent development challenges. Joint fellowships and professional exchanges with UK universities are building a pipeline of clinicians and data scientists skilled in responsible AI. Malaysia’s widespread use of English in higher education and professional settings facilitates direct adoption of technical curricula, guidelines and collaborative research without translation barriers, accelerating capacity building across institutions.
Strategic Priorities for AI Healthcare Growth
The table below summarises key strengths and opportunities across major domains of AI healthcare, highlighting strategic alignment between Malaysia and the UK:
Long-Term Aspirations for the UK–Malaysia AI Partnership
The UK–Malaysia partnership envisions a robust, ethical and interoperable AI healthcare system that prioritises data sovereignty, inclusion and global leadership. Key aspirational goals include:
Conclusion: Toward a Resilient AI-Enabled Future
Malaysia’s adoption of AI in healthcare is not merely a technological evolution it is a transformative step toward redefining care delivery, system efficiency and health equity. While the country leads its digital health journey independently, the United Kingdom serves as a valuable partner, offering regulatory insight, R&D support and proven governance models. Together, their collaboration paves the way for a healthcare future that is not only intelligent and responsive but also transparent, secure and inclusive.
Funding Statement
This work was supported by the United Kingdom Foreign, Commonwealth and Development Office (FCDO) and the British High Commission of Kuala Lumpur. The activities were conducted under the auspices of the Malaysian Industry-Government Group for High Technology (MIGHT), in partnership with Universiti Teknologi MARA (UiTM), Malaysia, and Leeds Beckett University, United Kingdom.
References
- Malay Mail. (2025, May). MOH Introduces AI-Powered X-Ray Screening to Boost Early Detection of Lung Disease. Retrieved from: https://www.malaymail.com/news/malaysia/2025/05/21/health-ministry-introduces-ai-screening-to-boost-early-lung-disease-detection/177530
- ITNews Asia. (2025). KPJ Healthcare Deploys AI Chatbot to Enhance Patient Services. Retrieved from: https://www.itnews.asia/news/malaysias-kpj-healthcare-deploys-ai-chatbot-to-enhance-patient-services-616947
- Pure Global (via LinkedIn). (2024, December). AI-Powered Medical Device Regulatory Strategy: Malaysia’s SaMD Pathway Explained. Retrieved from: https://www.linkedin.com/posts/pure-global_pure-global-ai-powered-medical-device-regulatory-activity-7222162771319091203-9nDO
- CodeBlue by Galen Centre. (2025, April). Doctors Hold Final Say in AI-Assisted Medical Decisions, Experts Say. Retrieved from: https://codeblue.galencentre.org/2025/04/doctors-hold-final-say-in-ai-assisted-medical-decisions-experts-say
